Paronychia
📧 Sign up to get email alerts when something new happens for Paronychia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors [Phase 2]
Phase 2 clinical trial evaluating topical HT-001 for treating EGFR inhibitor–related skin toxicities (acneiform eruption, xerosis cutis, and…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial. [Phase 3]
This clinical trial update reports a Phase 3 intraindividual randomized study evaluating two treatment regimens for chronic paronychia: intr…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia [Phase 3]
A Phase 3 trial is evaluating add-on timolol for paronychia induced by EGFR-TKI and ALK-TKI therapies; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Efficacy and Safety of Kinesiology Tape Wrapping for Paronychia Induced by Epidermal Growth Factor Receptor Inhibitors [NA]
A completed clinical study assessing the efficacy and safety of kinesiology tape wrapping for paronychia induced by EGFR inhibitors.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Efficacy and Safety of Timolol for TKI Induced Paronychia [Phase 3]
A Phase 3 clinical trial evaluating timolol for treatment of paronychia induced by TKIs, with efficacy and safety data yet to be reported.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment [Phase 4]
Phase 4 pilot study assessing the safety and efficacy of Nailprotex for onychomycosis (and chronic paronychia) has been completed.